|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 12.79 USD | +6.41% |
|
+3.98% | -20.31% |
| Apr. 05 | Hillevax Insider Sold Shares Worth $264,467, According to a Recent SEC Filing | MT |
| Mar. 21 | Stifel Adjusts HilleVax Price Target to $34 From $30, Maintains Buy Rating | MT |
HilleVax, Inc. reported earnings results for the fourth quarter ended December 31, 2023. For the fourth quarter, the company reported net loss was USD 36.96 million compared to USD 21.19 million a year ago. Basic loss per share from continuing operations was USD 0.78 compared to USD 0.56 a year ago.
Diluted loss per share from continuing operations was USD 0.78 compared to USD 0.56 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -20.31% | 616M | |
| +1.51% | 42.75B | |
| +49.22% | 41.61B | |
| +8.57% | 41.34B | |
| -12.36% | 26.59B | |
| +8.92% | 25.49B | |
| -25.13% | 18.12B | |
| +29.17% | 12.24B | |
| -3.12% | 11.76B | |
| +6.35% | 11B |
HILLEVAX, INC. 
